Obesity GLP-1 Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035 Industry Size (2025): USD 8,169 Mn Forecast (2035): USD 65,364 Mn CAGR (2025 to 2035): 23.1% Obesity GLP-1 Market Forecast and Outlook 2025 to 2035 The obesity GLP-1 market is projected to grow from USD 8169 million in 2025 to approximately USD 65,364 million by 2035, recording an absolute increase of USD 57,195 million over the forecast period
Pharmaceutical modifications to the GLP-1 molecule, including adding a fatty acid chain that binds to albumin, protect it from rapid breakdown
SF3B1 and BAP1 mutations in blue nevus-like melanoma
The medications work best as one component of a structured program - alongside nutrition, sleep, activity, and ongoing medical management